NCT07031323

OnTrackCF: Engagement, Feasibility, and Acceptability Study

• Status: Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 60 (estimated)
• Sponsor: Boston Children's Hospital · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This is a multi-site, nonrandomized study using mixed methods approach to evaluate the feasibility, acceptability, and user engagement of OnTrackCF for adults with Cystic Fibrosis (AWCF).

Conditions

• Cystic Fibrosis (CF)
• Cystic Fibrosis - Complete

Interventions

Type	Name	Description
BEHAVIORAL	OnTrackCF	OnTrackCF is a mHealth application co-developed with Upstream Dream. It is designed specifically to track and support adherence to CFTR modulator therapy. The app allows users to track their modulator intake and disease symptoms while supporting their adherence goals using Behavioral Change Techniques (BCTs) with empirical evidence of efficacy. The BCTs are administered primarily in the form of messages designed to deliver specific BCTs. The app sends up to 3 adherence support messages per day and provides detailed data to the user about their adherence levels, adherence goals, and disease symptoms. This process will continue until we reach an N=60 AWCF enrolled OR demonstrate that we have achieved 12 weeks of sustained user engagement with the app.

Timeline

• Start date: 2025-11-20
• Primary completion: 2026-09-01
• Completion: 2026-12-01
• First posted: 2025-06-22
• Last updated: 2025-12-05

Locations

3 sites across 1 country: United States